Stay updated on Durvalumab and Daratumumab in MM Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - The page adds a MedlinePlus Genetics topic: Multiple myeloma. This expands the page’s coverage to include a genetics-focused overview of this blood cancer, highlighting its genetic aspects for readers seeking authoritative medical information.
    Difference
    0.2%
    Check dated 2025-10-20T07:37:50.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on multiple myeloma, reducing access to genetic information about this condition.
    Difference
    0.2%
    Check dated 2025-10-13T05:39:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has updated its revision from v3.1.0 to v3.2.0, added a government-status notice about potential delays and operating status, and linked a new MedlinePlus Genetics topic (Multiple myeloma).
    Difference
    3%
    Check dated 2025-10-06T04:23:52.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Core content updated: 'Plasma cell myeloma' replaced with 'Multiple myeloma' and revision updated to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T23:54:36.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Updated to version v3.0.2. The MedlinePlus Genetics related topics: Multiple myeloma entry was removed, along with the Back to Top link and the previous v3.0.1 revision note.
    Difference
    0.3%
    Check dated 2025-09-14T18:43:09.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T13:09:49.000Z thumbnail image

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.